Bioceres Crop Solutions Corp.
BIOX
Positions held
Your positionsBIOX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $20.94M | Enterprise value | $270.47M | Trailing P/E | — | Forward P/E | 0.51 |
| PEG | 1.04 | Price / book | 0.53 | Beta | 0.47 | Dividend yield | 0.00% |
| Revenue growth | -23.4% | Earnings growth | — | Gross margin | 34.7% | Operating margin | -16.0% |
| Profit margin | -19.7% | ROE | -28.1% | ROA | -0.1% | Debt / equity | 3.69 |
| Current ratio | 0.81 | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $2.19 | 52w low | $0.30 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | — | $38.2M | $73.7M | $77.4M | $74.4M | $50.1M |
| Op margin | — | -12.6% | 10.6% | 10.0% | -9.3% | 10.8% |
| Net income | — | -$9.0M | -$183M | -$7.3M | -$47.9M | $2.6M |
| Gross margin | — | 33.2% | 35.7% | 46.0% | 31.4% | 36.1% |
| Gross profit | — | $12.7M | $26.3M | $35.6M | $23.3M | $18.1M |
| Operating income | — | -$4.8M | $7.8M | $7.8M | -$6.9M | $5.4M |
- Revenue -48% vs prior quarter ($38M vs $74M).
- Gross margin 33.2% (was 35.7% prior quarter).
- Operating margin compressed to -12.6%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | — | $333M | $465M | $419M | $328M |
| Op margin | — | -0.2% | 9.5% | 12.7% | 13.5% |
| Net income | — | -$55.4M | $4.3M | $18.8M | -$7.2M |
| Gross margin | — | 38.4% | 39.2% | 42.6% | 38.0% |
| Gross profit | — | $128M | $182M | $179M | $125M |
| Operating income | — | -$0.8M | $44.1M | $53.2M | $44.2M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-15 · Bioceres Crop Solutions Corp (BIOX) (Q4 2026) Earnings Call Highlights: Q4 Revenue Stabilizes ...
2026-09-15 · Bioceres (BIOX) Q4 2026 Earnings Call Transcript
2026-09-15 · Bioceres Crop Solutions Corp. Q4 2026 Earnings Call Summary
2026-09-14 · Bioceres Crop: Fiscal Q4 Earnings Snapshot
2026-09-14 · Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
2026-07-21 · Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection
Price (daily)
Full chart · RSI · MACD · patterns